CompoAtlas

Fecondil - Homme

Food supplement declared in France, declaration No 2016-12-147

Fecondil - Homme (Nurilia) is a food supplement declared in France. Status: withdrawn from the market on 1 August 2019. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.

Brand
Nurilia
Food business operator placing the product on the market
NURIBIOL
Status
Withdrawn from the market on 1 August 2019
Form
Tablet
Daily dose
1
Directions for use
Prendre un comprimé par jour avec un verre d'eau
Intended populations
Men

Declaration 201540, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Opuntia ficus-indica (L.) Mill.FruitPoudre (de plantes séchées ou broyées)100 mg

Other active ingredients

NamePer day
Acétylcystéinenot declared

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
acide (6S)-5-méthyltétrahydrofolique sous forme de sel de glucosamineFolates (vitamine B9)1,000 µg200 µg
NicotinamideNicotinamide (vitamine B3)900 mg54 mg
CyanocobalamineVitamine B12pas d'effet indésirable définidose annulled by the French Council of State in 2011
RiboflavineVitamine B2 (riboflavine)pas de limite (données insuffisantes)dose annulled by the French Council of State in 2011
Chlorhydrate de pyridoxineVitamine B612 mg2 mg
Succinate acide de D-alpha-tocophéryleVitamine E300 mg30 mg
Bisglycinate de zincZinc25 mg15 mg

Additives

E420, E470b, E341

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Label warnings

Une consommation excessive peut avoir des effets laxatifs

Regulatory points

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Acétylcystéine
    Read the warning, when it applies and the studies cited

    N-ACETYL-L-CYSTEINE

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have kidney stones (Fauci et al. 1998; Mårtensson et al. 1990).

    Sources cited by Health Canada (2)
    • Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper DI, Hauser SL and Longo DL, editors. Harrison's Principles of Internal Medicine, 14th edition. Toronto (ON): McGraw-Hill Health Professions Division; 1998.
    • Mårtensson J, Denneberg T, Lindell Å, Textorius O. Sulfur amino acid metabolism in cystinuria : A biochemical and clinical study of patients. Kidney International 1990;37:143-149. PubMed

    Contraindications

    Do not use if you are taking antibiotics or nitroglycerin (Repchinsky 2008; Cederlund and Märdh 1993; Parry and Neu 1977; Ardissino et al. 1997).

    Sources cited by Health Canada (4)
    • Ardissino D, Merlini PA, Savonitto S, Demicheli G, Zanini P, Bertocchi F, Falcone C, Ghio S, Marinoni G, Montemartini C, Mussini A. Effect of transdermal nitroglycerin or N- acetylcysteine, or both, in the long-term treatment of unstable angina pectoris. Journal of the American College of Cardiology 1997;29(5):941-947. PubMed Randomised trial
    • Cederlund H, Märdh PA. Antibacterial activities of non-antibiotic drugs. Journal of Antimicrobial Chemotherapy 1993;32:355-365. PubMed Review article
    • Parry MF, Neu HC. Effect of N-acetylcysteine on antibiotic activity and bacterial growth in vitro. Journal of Clinical Microbiology 1977;5(1);58-61.
    • Repchinsky C, editor. Compendium of Pharmaceuticals and Specialties. The Canadian Drug Reference for Health Professionals. Ottawa (ON): Canadian Pharmacists Association; 2008.

    Health Canada monograph dated 19 December 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Brand : Nurilia

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line